1,086
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Thermally sensitive fluorescence imaging system for radiofrequency ablation guidance

, , , , , , & ORCID Icon show all
Pages 308-315 | Received 24 Dec 2019, Accepted 06 Mar 2020, Published online: 31 Mar 2020

References

  • Mahnken AH, Pereira PL, de Baère T. Interventional oncologic approaches to liver metastases. Radiology. 2013;266(2):407–430.
  • Venkatesan AM, Wood BJ, Gervais DA. Percutaneous ablation in the kidney. Radiology. 2011;261(2):375–391.
  • Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
  • Komorizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003;97(5):1253–1262.
  • Lee HY, Rhim H, Lee MW, et al. Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors. Eur Radiol. 2013;23(1):190–197.
  • Poch FG, Rieder C, Ballhausen H, et al. The vascular cooling effect in hepatic multipolar radiofrequency ablation leads to incomplete ablation ex vivo. Int J Hypertherm. 2016;32(7):749–756.
  • Ahmed M, Solbiati L, Brace CL, et al.; For the International Working Group on Image-guided Tumor Ablation, Interventional Oncology Sans Frontières Expert Panel, Technology Assessment Committee of the Society of Interventional Radiology, and the Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273(1):241–260.
  • Zhang N, Ma D, Wang L, et al. Insufficient radiofrequency ablation treated hepatocellular carcinoma cells promote metastasis by up-regulation ITGB3. J Cancer. 2017;8(18):3742–3754.
  • Zhao Z, Wu J, Liu X, et al. Insufficient radiofrequency ablation promotes proliferation of residual hepatocellular carcinoma via autophagy. Cancer Lett. 2018;421:73–81.
  • Su T, Liao J, Dai Z, et al. Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation. Oncogene. 2018;37(26):3514–3527.
  • Gao D, Gao L, Zhang C, et al. A near-infrared phthalocyanine dye-labeled agent for integrin alphavbeta6-targeted theranostics of pancreatic cancer. Biomaterials. 2015;53:229–238.
  • Guo X, Ling X, Du F, et al. Molecular imaging of pancreatic duct adenocarcinoma using a type 2 cannabinoid receptor-targeted near-infrared fluorescent probe. Transl Oncol. 2018;11(5):1065–1073.
  • Huynh AS, Chung WJ, Cho HI, et al. Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy. J Med Chem. 2012;55(22):9751–9762.
  • van Dam GM, Themelis G, Crane LM, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med. 2011;17(10):1315–1319.
  • Crane LM, Themelis G, Arts HJ, et al. Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results. Gynecol Oncol. 2011;120(2):291–295.
  • Terwisscha van Scheltinga AG, van Dam GM, Nagengast WB, et al. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J Nucl Med: Soc Nucl Med. 2011;52(11):1778–1785.
  • Chen X, Park R, Shahinian AH, et al. Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation. Nucl Med Biol. 2004;31(1):11–19.
  • Schols RM, Connell NJ, Stassen LP. Near-infrared fluorescence imaging for real-time intraoperative anatomical guidance in minimally invasive surgery: a systematic review of the literature. World J Surg. 2015;39(5):1069–1079.
  • Wang C, Wang Z, Zhao T, et al. Optical molecular imaging for tumor detection and image-guided surgery. Biomaterials. 2018;157:62–75.
  • Au JT, Gonzalez L, Chen CH, et al. Bioluminescence imaging serves as a dynamic marker for guiding and assessing thermal treatment of cancer in a preclinical model. Ann Surg Oncol. 2012;19(9):3116–3122.
  • Trajkovic-Arsic M, Mohajerani P, Sarantopoulos A, et al. Multimodal molecular imaging of integrin alphavbeta3 for in vivo detection of pancreatic cancer. J Nucl Med: Soc Nucl Med. 2014;55(3):446–451.
  • Taherian A, Li X, Liu Y, et al. Differences in integrin expression and signaling within human breast cancer cells. BMC Cancer. 2011;11(1):293.
  • Liu Z, Yu L, Wang X, et al. Targeted RGD peptide based probe for cancer optical imaging. CPPS. 2016;17:570–581.
  • Cheng Z, Wu Y, Xiong Z, et al. Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice. Bioconjug Chem. 2005;16(6):1433–1441.
  • Schottelius M, Laufer B, Kessler H, et al. Ligands for mapping alphavbeta3-integrin expression in vivo. Acc Chem Res. 2009;42(7):969–980.
  • Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol. 2001;19(4):316–317.
  • Yuan L, Lin W, Zheng K, et al. Far-red to near infrared analyte-responsive fluorescent probes based on organic fluorophore platforms for fluorescence imaging. Chem Soc Rev. 2013;42(2):622–661.
  • Deng X, Li K, Cai X, et al. A hollow-structured CuS@Cu2 S@Au nanohybrid: synergistically enhanced photothermal efficiency and photoswitchable targeting effect for cancer theranostics. Adv Mater. 2017;29(36):1701266.
  • Sun M, Peng D, Hao H, et al. Thermally triggered in situ assembly of gold nanoparticles for cancer multimodal imaging and photothermal therapy. ACS Appl Mater Interfaces. 2017;9:10453–10460.
  • Yan F, Wang S, Yang W, et al. Tumor-penetrating peptide-integrated thermally sensitive liposomal doxorubicin enhances efficacy of radiofrequency ablation in liver tumors. Radiology. 2017;285(2):462–471.